ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 194 out of 670

$418K Total Retail Price of All Prescriptions

Rank: 249 out of 670

239 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 239 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

36% of this provider’s 239 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,009 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 1,079 1,061 S3 1 1
LEVOTHYROXINE SODIUM 313 299 2 2
MIRTAZAPINE 291 280 3 59
FUROSEMIDE 266 261 4 6
METOPROLOL TARTRATE 242 241 5 9
NAMENDA 228 228 6 54
WARFARIN SODIUM 218 211 7 13
LISINOPRIL 205 204 8 3
SIMVASTATIN 180 162 9 4
TRAZODONE HCL 169 169 10 39
AMLODIPINE BESYLATE 168 155 11 7
LANTUS 136 123 12 58
NOVOLOG 128 116 13 151
SERTRALINE HCL 121 112 14 22
OMEPRAZOLE 114 110 15 5
OXYCODONE-ACETAMINOPHEN 106 80 S2 16 77
SODIUM CHLORIDE 106 106 16 170
DONEPEZIL HCL 97 97 18 31
POTASSIUM CHLORIDE 96 92 19 16
GABAPENTIN 95 74 20 11
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 88 21 93
EXELON 94 94 21 128
IPRATROPIUM-ALBUTEROL 78 77 23 136
OXYCODONE HCL-ACETAMINOPHEN 76 73 S2 24 71
FENTANYL 76 74 S2 24 76
CITALOPRAM HBR 73 72 26 20
PREDNISONE 71 66 27 40
ALBUTEROL SULFATE 64 46 28 133
QUETIAPINE FUMARATE 64 62 28 84
LEVOFLOXACIN 61 53 30 88
SPIRIVA 58 58 31 51
CARBIDOPA-LEVODOPA 57 57 32 101
ATENOLOL 57 45 32 17
LACTULOSE 57 57 32 107
LANSOPRAZOLE 54 54 35 86
CARVEDILOL 53 53 36 29
TAMSULOSIN HCL 52 52 37 30
SINGULAIR 51 51 38 56
BACLOFEN 50 22 39 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.